
IN FOCUS: Could Longevity Medicine Change How We Treat Endometriosis?
Notas del episodio
Endometriosis affects an estimated 200 million women worldwide, yet research has historically framed it as a purely gynaecological problem — managed mainly through surgery or hormonal suppression.
In this clip from How To Be A Woman, Professor Andrea Maier suggests a different perspective: what if endometriosis is also connected to the biology of ageing?
She explains how hallmarks of ageing — such as chronic inflammation, immune dysfunction, mitochondrial impairment and microbiome imbalance — are already present in many women’s health conditions, including endometriosis and PCOS. This opens the possibility that geroscience and longevity medicine could help uncover new mechanisms — and new treatments.
The conversation touches on:
* Why endometriosis is still dramatically understudied
* The limits of current treatment options
* How repurposed longevity drugs may offer new hope
* Why quality of life matters as much as lifespan
* The urgent need for better-designed, collaborative trials
🎧 Watch or Listen to the full episode:
HOW TO STAY ALIVE: Longevity Medicine, NAD, Peptides & What Actually Works
➤https://thewomanshandbook.substack.com/p/how-to-stay-alive-is-longevity-medicine?r=5h5ltd
This episode is part of How To Be A Woman, the podcast from The Woman’s Handbook, exploring women’s health from menarche to matriarchy — with science, nuance, and zero hype.
🔗 https://www.thewomanshandbook.com
📸 https://www.instagram.com/thewomanshandbook?igsh=YXF1aGw3MDZwdnZi
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thewomanshandbook.substack.com